+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Tract Testing Products Market by Technology, Product Type, Sample Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Respiratory Tract Testing Products Market by Technology, Product Type, Sample Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Respiratory Tract Testing Products Market by Technology, Product Type, Sample Type, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 190 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6078950
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Transforming Respiratory Testing with In-Depth Analytical Perspectives

The respiratory tract testing industry stands at a pivotal juncture, energized by technological breakthroughs and shifting regulatory environments. As rising infection rates and emerging pathogens have amplified the demand for accurate, rapid diagnostics, stakeholders across healthcare systems are placing unprecedented emphasis on resilient testing solutions. From high-throughput laboratory platforms to decentralized point-of-care devices, the quest for sensitivity, specificity, and speed underpins every innovation. In parallel, the convergence of digital health tools with laboratory information management systems is redefining how data is collected, analyzed, and acted upon, forging new pathways to patient-centric care.

Recognizing the complexity and dynamism of this market, this executive summary distills critical developments and strategic insights that will shape respiratory diagnostics in the near term. By integrating tariff analyses, segmentation deep-dives, regional perspectives, and competitive intelligence, we provide a cohesive narrative that empowers decision-makers. Whether you are steering R&D investments, navigating supply chain challenges, or optimizing go-to-market strategies, the insights presented here offer a grounded foundation for actionable planning and sustained growth.

Unveiling Pivotal Shifts Reshaping Respiratory Diagnostics

Recent years have witnessed transformative shifts that transcend incremental improvements, propelling respiratory testing into a new era of precision and accessibility. The rapid adoption of molecular assays, particularly real-time and digital PCR, has elevated detection thresholds to unprecedented levels, enabling the identification of low viral loads long before clinical symptoms manifest. Simultaneously, lateral flow immunoassays have matured into robust, user-friendly tools suitable for decentralized settings, bridging the gap between centralized labs and remote clinics.

Concurrently, the integration of artificial intelligence and machine learning algorithms has begun to optimize assay design, automate image analysis for staining techniques, and predict outbreak trajectories based on real-time data streams. Investment in point-of-care analytical instruments is fostering a shift toward immediate decision support at the bedside, while expansion of cloud-based LIMS solutions is streamlining data exchange across healthcare networks. Together, these advancements signal a departure from siloed diagnostics toward an interconnected ecosystem in which agility, interoperability, and data integrity drive competitive advantage.

Assessing the Ripple Effects of United States Tariffs on 2025 Testing Solutions

The introduction of new import duties and tariff adjustments by the United States in early 2025 has introduced both obstacles and opportunities within the respiratory testing market. By increasing the cost base for key reagents, instruments, and consumables imported from affected regions, these measures are compelling manufacturers to reassess global sourcing strategies. For some suppliers, the burden of higher duties has translated into margin compression, prompting renegotiations with component vendors and accelerated investment in domestic production capabilities.

Yet this same environment has catalyzed innovation, as companies explore alternative raw materials and develop modular instrument platforms adaptable to localized assembly. Additionally, diagnostic developers are seeking to mitigate risk through strategic partnerships with U.S.-based contract manufacturing organizations and by expanding capacity in duty-exempt zones. While short-term pricing pressures persist, the redirection of supply chains toward domestic or preferential trade partners promises increased resilience and reduced lead times in the medium term, reshaping competitive dynamics across the industry.

Dissecting Market Segments to Reveal Core Growth Drivers

A granular examination of the market through multiple segmentation lenses illuminates the most dynamic growth corridors and latent opportunities. When considering division by technology, the market encompasses immunodiagnostics with ELISA assays and lateral flow formats, microbiology tests spanning both culture methodologies and staining protocols, as well as molecular tests that include isothermal amplification techniques and polymerase chain reaction platforms, among which digital PCR and real-time PCR have emerged as cornerstone innovations. From the standpoint of product type, offerings range from consumables such as controls and calibrators alongside kits and reagents to instruments that include both high-throughput analytical systems and portable point-of-care devices, complemented by software and services encompassing laboratory information management systems as well as maintenance and technical support.

Turning to sample types reveals that bronchoalveolar lavage specimens, nasopharyngeal and oropharyngeal swabs, saliva, and sputum each command distinct validation protocols and market demand profiles. End users span rigorous clinical laboratory environments, home care and self-testing contexts, traditional hospital settings, and decentralized point-of-care testing sites, each requiring tailored distribution and training models. Distribution channels themselves vary from direct tender agreements and hospital pharmacy procurement to online sales platforms and retail pharmacy networks. Synthesizing these segmentation insights enables stakeholders to align product development roadmaps and commercialization strategies with the specific needs and regulatory landscapes of each cohort.

Mapping Regional Variations Driving Respiratory Test Adoption

Geographic markets exhibit unique trajectories informed by regulatory frameworks, healthcare infrastructure, and purchasing mechanisms. In the Americas, well-established reimbursement structures and a culture of early adoption have fostered robust uptake of advanced molecular diagnostics, while ongoing public health initiatives continue to expand access to rapid testing in community settings. North America’s emphasis on decentralized testing has also spurred adoption of user-friendly point-of-care solutions and telehealth-linked platforms.

Across Europe, Middle East & Africa, the market is characterized by regulatory diversity and variable healthcare budgets. In Western Europe, stringent quality standards and centralized procurement drive demand for high-sensitivity assays, whereas in emerging markets within the Middle East and Africa, growth is underpinned by investments in laboratory capacity building and public-private partnerships aimed at improving diagnostic reach. Infrastructure gaps are being bridged through portable diagnostic kits and training programs that enhance local testing proficiency.

Asia-Pacific presents a dynamic landscape where healthcare modernization efforts in China, India, and Southeast Asian nations are fueling demand for both high-throughput laboratory systems and cost-effective point-of-care diagnostics. Government incentives for local manufacturing, coupled with regulatory harmonization initiatives, are enabling faster product registrations and supporting the rapid scaling of testing networks. These regional nuances shape the strategic priorities for market participants aiming to optimize resource allocation and drive localized innovation.

Spotlight on Leading Players Steering Innovation and Expansion

Industry leaders are demonstrating a competitive commitment to innovation, scale, and strategic partnerships. Major instrument manufacturers are directing R&D budgets toward next-generation sequencing integration and digital PCR platforms, enhancing multiplexing capabilities for simultaneous pathogen detection. Leading reagent suppliers are forging alliances with point-of-care device companies to co-develop pre-validated kits that streamline end-user workflows. Software vendors are investing in advanced analytics modules and interoperability standards to meet the rising demand for real-time data integration across diverse healthcare IT ecosystems.

Several key mergers and acquisitions have reshaped the competitive landscape, consolidating market positions in high-growth segments and enabling vertical integration from reagent production to software deployment. Collaborative agreements between instrument providers and academic research centers have accelerated the validation of novel biomarkers and assay protocols. Meanwhile, smaller agile players are gaining visibility through niche offerings in lateral flow innovations and isothermal amplification assays, leveraging strategic distribution partnerships to access broader markets. Collectively, these corporate maneuvers underscore a strategic pivot toward end-to-end solutions that address both clinical and operational imperatives.

Strategic Recommendations to Enhance Competitive Positioning

Organizations seeking to fortify their market position should prioritize investment in agile manufacturing capabilities and flexible platform architectures that can accommodate shifting regulatory requirements, including evolving import duty structures. Engaging proactively with regulatory bodies to clarify compliance pathways will expedite product registrations and minimize time to market. Companies should also evaluate partnerships with domestic contract manufacturers to reduce exposure to tariff volatility and shorten supply chain lead times. Incorporating digital health components into product portfolios-such as integrated data analytics, telehealth connectivity, and AI-driven decision support-will differentiate offerings and address growing demands for holistic care models.

Additionally, segment-specific go-to-market strategies are essential. Tailored training programs for home care and point-of-care users can drive adoption in non-traditional settings, while collaborative pilot projects with large clinical laboratories can demonstrate clinical utility and build confidence among key opinion leaders. Value-based pricing frameworks that align reimbursement incentives with performance outcomes will further enhance market penetration and foster long-term customer loyalty.

Robust Methodologies Underpinning Our Research Rigor

Our research approach integrates primary and secondary sources to ensure analytical rigor and data reliability. We conducted in-depth interviews with C-level executives, R&D directors, and supply chain managers across leading diagnostic firms, academic institutions, and contract manufacturing organizations to capture firsthand perspectives on emerging trends and operational challenges. Secondary research encompassed an extensive review of peer-reviewed journals, regulatory filings, patent databases, and market intelligence repositories, supplemented by publicly available financial reports and investor presentations.

Data points and qualitative insights were triangulated to validate consistency and uncover potential anomalies. Industry terminology and segmentation frameworks were aligned with established standards to facilitate cross-comparison. Quality control measures included iterative peer reviews by subject matter experts and cross-functional audits to confirm that our findings reflect the most current industry landscape. This methodology ensures that strategic recommendations are grounded in robust evidence and are directly applicable to stakeholder decision processes.

Synthesizing Insights to Navigate Emerging Challenges

As the respiratory tract testing market navigates tariff adjustments, shifting regulatory landscapes, and rapid technological progression, stakeholders are positioned to capitalize on emerging opportunities by aligning resources with validated segmentation and regional strategies. The synthesis of competitive intelligence demonstrates that strategic partnerships, digital integration, and supply chain resilience will define market leadership. Companies that embrace modular, platform-agnostic designs and proactively engage with diverse end users stand to capture significant market share.

Ultimately, the path to sustained growth lies in harmonizing innovation with operational excellence. By leveraging the collective insights presented in this report-from granular segmentation analyses to high-level regional dynamics-decision-makers can chart a course that mitigates risk, accelerates time to value, and delivers superior diagnostic solutions that meet evolving healthcare demands.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Immunodiagnostics
      • Elisa
      • Lateral Flow Assays
    • Microbiology Tests
      • Culture
      • Staining
    • Molecular Tests
      • Isothermal Amplification
      • PCR
        • Digital PCR
        • Real Time
  • Product Type
    • Consumables
      • Controls & Calibrators
      • Kits & Reagents
    • Instruments
      • Analytical Instruments
      • Point Of Care Devices
    • Software & Services
      • LIMS Software
      • Maintenance & Support
  • Sample Type
    • Bronchoalveolar Lavage
    • Nasopharyngeal Swab
    • Oropharyngeal Swab
    • Saliva
    • Sputum
  • End User
    • Clinical Laboratories
    • Home Care & Self Testing
    • Hospitals
    • Point Of Care Testing
  • Distribution Channel
    • Direct Tender
    • Hospital Pharmacy
    • Online Sales
    • Retail Pharmacy
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Qiagen N.V.
  • bioMérieux S.A.
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Respiratory Tract Testing Products Market, by Product Type
8.1. Introduction
8.2. Consumables
8.2.1. Centrifuge Tubes
8.2.2. Microplates
8.2.3. Pipette Tips
8.3. Instruments
8.3.1. Immunoassay Analyzers
8.3.1.1. Automated Analyzers
8.3.1.2. Manual Analyzers
8.3.2. Molecular Diagnostics Instruments
8.3.3. PCR Systems
8.3.3.1. Digital PCR Systems
8.3.3.2. Real-Time PCR Systems
8.4. Kits & Reagents
8.4.1. Amplification Kits
8.4.1.1. Endpoint PCR Kits
8.4.1.2. Real-Time PCR Kits
8.4.2. Immunoassay Reagents
8.4.3. Nucleic Acid Isolation Kits
8.4.3.1. DNA Extraction Kits
8.4.3.2. RNA Extraction Kits
8.4.4. Probe Systems
9. Respiratory Tract Testing Products Market, by Test Type
9.1. Introduction
9.2. Antibody Tests
9.3. Antigen Tests
9.4. Molecular Tests
9.4.1. NAATs
9.4.2. PCR Tests
9.5. Serological Tests
9.5.1. ELISA Tests
9.5.2. Lateral Flow Assays
10. Respiratory Tract Testing Products Market, by Application
10.1. Introduction
10.2. Cancer Screening
10.2.1. Lung Cancer
10.2.2. Throat Cancer
10.3. Infectious Disease Testing
10.3.1. COVID-19
10.3.2. Influenza
10.3.3. Tuberculosis
10.4. Metagenomics
10.5. Pathogen Specific Tests
11. Respiratory Tract Testing Products Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Ambulatory Care Centers
11.4. Diagnostic Laboratories
11.4.1. Central Laboratories
11.4.2. Independent Laboratories
11.5. Hospitals
11.5.1. In-Patient Care
11.5.2. Out-Patient Care
12. Respiratory Tract Testing Products Market, by Sample Type
12.1. Introduction
12.2. Nasal Swabs
12.2.1. Anterodorsal Swabs
12.2.2. Deep Nasal Swabs
12.3. Serum
12.4. Sputum
12.5. Throat Swabs
13. Respiratory Tract Testing Products Market, by Technology
13.1. Introduction
13.2. Hybridization
13.3. Next-Generation Sequencing
13.4. PCR Technology
13.4.1. Multiplex PCR
13.4.2. Real-Time PCR
14. Respiratory Tract Testing Products Market, by Purchase Location
14.1. Introduction
14.2. In-Hospital Pharmacies
14.3. Online Pharmacies
14.4. Point of Care
14.5. Retail Pharmacies
14.5.1. Chain Pharmacies
14.5.2. Independent Pharmacies
15. Respiratory Tract Testing Products Market, by Price Tier
15.1. Introduction
15.2. Economy
15.3. Mid-Range
15.4. Premium
16. Americas Respiratory Tract Testing Products Market
16.1. Introduction
16.2. Argentina
16.3. Brazil
16.4. Canada
16.5. Mexico
16.6. United States
17. Asia-Pacific Respiratory Tract Testing Products Market
17.1. Introduction
17.2. Australia
17.3. China
17.4. India
17.5. Indonesia
17.6. Japan
17.7. Malaysia
17.8. Philippines
17.9. Singapore
17.10. South Korea
17.11. Taiwan
17.12. Thailand
17.13. Vietnam
18. Europe, Middle East & Africa Respiratory Tract Testing Products Market
18.1. Introduction
18.2. Denmark
18.3. Egypt
18.4. Finland
18.5. France
18.6. Germany
18.7. Israel
18.8. Italy
18.9. Netherlands
18.10. Nigeria
18.11. Norway
18.12. Poland
18.13. Qatar
18.14. Russia
18.15. Saudi Arabia
18.16. South Africa
18.17. Spain
18.18. Sweden
18.19. Switzerland
18.20. Turkey
18.21. United Arab Emirates
18.22. United Kingdom
19. Competitive Landscape
19.1. Market Share Analysis, 2024
19.2. FPNV Positioning Matrix, 2024
19.3. Competitive Analysis
19.3.1. Abbott Laboratories
19.3.2. BD (Becton, Dickinson and Company)
19.3.3. BioMérieux SA
19.3.4. Danaher Corporation
19.3.5. Hologic, Inc.
19.3.6. Luminex Corporation
19.3.7. Quest Diagnostics Incorporated
19.3.8. Quidel Corporation
19.3.9. Roche Diagnostics
19.3.10. Siemens Healthineers AG
19.3.11. Thermo Fisher Scientific Inc.
20. ResearchAI
21. ResearchStatistics
22. ResearchContacts
23. ResearchArticles
24. Appendix
List of Figures
FIGURE 1. RESPIRATORY TRACT TESTING PRODUCTS MARKET MULTI-CURRENCY
FIGURE 2. RESPIRATORY TRACT TESTING PRODUCTS MARKET MULTI-LANGUAGE
FIGURE 3. RESPIRATORY TRACT TESTING PRODUCTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 18. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2024 VS 2030 (%)
FIGURE 20. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2024 VS 2030 (%)
FIGURE 22. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 26. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 30. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 31. RESPIRATORY TRACT TESTING PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 32. RESPIRATORY TRACT TESTING PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RESPIRATORY TRACT TESTING PRODUCTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CENTRIFUGE TUBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MICROPLATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PIPETTE TIPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AUTOMATED ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MANUAL ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIGITAL PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY REAL-TIME PCR SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY ENDPOINT PCR KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY REAL-TIME PCR KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DNA EXTRACTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RNA EXTRACTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PROBE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY ANTIBODY TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NAATS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY ELISA TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY THROAT CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COVID-19, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY METAGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PATHOGEN SPECIFIC TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CENTRAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IN-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY OUT-PATIENT CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY ANTERODORSAL SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DEEP NASAL SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SPUTUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY THROAT SWABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MULTIPLEX PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2018-2030 (USD MILLION)
TABLE 85. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IN-HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 86. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 87. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 88. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 89. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 90. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 91. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 92. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 93. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY ECONOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 94. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MID-RANGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 95. GLOBAL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PREMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 109. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 110. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 112. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 113. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 114. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, 2018-2030 (USD MILLION)
TABLE 115. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2018-2030 (USD MILLION)
TABLE 118. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 119. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 120. AMERICAS RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 130. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, 2018-2030 (USD MILLION)
TABLE 131. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 132. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 169. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 171. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 172. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 173. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 174. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 175. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, 2018-2030 (USD MILLION)
TABLE 176. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, 2018-2030 (USD MILLION)
TABLE 177. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 178. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, 2018-2030 (USD MILLION)
TABLE 179. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 180. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 182. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 183. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 185. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 186. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 187. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, 2018-2030 (USD MILLION)
TABLE 188. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 190. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2018-2030 (USD MILLION)
TABLE 191. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 192. CANADA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 193. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 194. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 195. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 196. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 197. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 198. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 199. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, 2018-2030 (USD MILLION)
TABLE 200. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, 2018-2030 (USD MILLION)
TABLE 201. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 202. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, 2018-2030 (USD MILLION)
TABLE 203. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 204. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 206. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 207. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 209. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 210. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 211. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, 2018-2030 (USD MILLION)
TABLE 212. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2018-2030 (USD MILLION)
TABLE 215. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. MEXICO RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 219. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 220. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 221. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 222. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 223. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, 2018-2030 (USD MILLION)
TABLE 224. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, 2018-2030 (USD MILLION)
TABLE 225. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, 2018-2030 (USD MILLION)
TABLE 227. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 228. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 230. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 231. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 233. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 234. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 235. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, 2018-2030 (USD MILLION)
TABLE 236. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 237. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 238. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2018-2030 (USD MILLION)
TABLE 239. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 240. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 241. UNITED STATES RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 242. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 244. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 245. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 246. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 248. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, 2018-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, 2018-2030 (USD MILLION)
TABLE 250. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, 2018-2030 (USD MILLION)
TABLE 252. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 256. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 258. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 260. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, 2018-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRICE TIER, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 267. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 269. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 271. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR SYSTEMS, 2018-2030 (USD MILLION)
TABLE 272. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY KITS & REAGENTS, 2018-2030 (USD MILLION)
TABLE 273. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY AMPLIFICATION KITS, 2018-2030 (USD MILLION)
TABLE 274. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NUCLEIC ACID ISOLATION KITS, 2018-2030 (USD MILLION)
TABLE 275. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 276. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY MOLECULAR TESTS, 2018-2030 (USD MILLION)
TABLE 277. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
TABLE 278. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY CANCER SCREENING, 2018-2030 (USD MILLION)
TABLE 280. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 281. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 283. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 284. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 285. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY NASAL SWABS, 2018-2030 (USD MILLION)
TABLE 286. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 288. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY PURCHASE LOCATION, 2018-2030 (USD MILLION)
TABLE 289. AUSTRALIA RESPIRATORY TRACT TESTING PRODUCTS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 290. AUSTRALIA RESPIRA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Respiratory Tract Testing Products market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Qiagen N.V.
  • bioMérieux S.A.
  • Hologic, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.

Related Topics

Related Reports

Mucosal Atomization Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Mucosal Atomization Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Respiratory Monitoring Systems Market by Product Type, Technology Type, End User, Application, Patient Type - Global Forecast to 2030 - Product Image

Respiratory Monitoring Systems Market by Product Type, Technology Type, End User, Application, Patient Type - Global Forecast to 2030

  • Report
  • 186 Pages
  • Global
From
Sleep Apnea Diagnostic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Sleep Apnea Diagnostic Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Medical Respiratory Mask Market by Product, End User, Distribution Channel, Type, Material, Technology - Global Forecast to 2030 - Product Image

Medical Respiratory Mask Market by Product, End User, Distribution Channel, Type, Material, Technology - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Air Compressor Nebulizers - Global Strategic Business Report - Product Image

Air Compressor Nebulizers - Global Strategic Business Report

  • Report
  • 381 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.